Hypotension Drug Development Pipeline Analysis Report 2018 - ResearchAndMarkets.com

DUBLIN--()--The "2018 Hypotension Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Hypotension Market" report has been added to ResearchAndMarkets.com's offering.

Hypotension affects an estimated 80 million population in the US and is one of the leading contributors to mortality. When the systolic and diastolic pressures are below 90/60, the condition is considered as Hypotension or low blood pressure, resulting in inadequate supply to the body parts. Different types of hypotension include- chronic asymptomatic hypotension, Orthostatic Hypotension, Neurally Mediated Hypotension and Severe Hypotension

To assist researchers, investors and business development managers, the publisher has come up with a comprehensive report on Hypotension pipeline. The report provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials). Drugs under development directly and through combination with other drugs are also included.

Current status, developmental phase, participating companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Hypotension pipeline product. Mechanism of Action and the target area of the pipeline product are also provided. Further, clinical and preclinical trials along with results of the trials are also included in the report.

In addition to complete details of each product, the report provides key trends in Hypotension pipeline studies. The products under development are categorized according to their development phase, mechanism and company to provide detailed insights into the type of drugs being developed and the stages of development.

Companies Mentioned

  • BrePco Biopharma Ltd
  • La Jolla Pharmaceutical Company
  • Orient Europharma Co., Ltd.
  • Theravance Biopharma Inc
  • TrioxBio Inc

Key Topics Covered:

1 Table of Contents

2 Hypotension Pipeline Analysis

3 Hypotension- Company Wise Pipeline Analysis

4 Hypotension R&D Pipeline Snapshots

5 Recent Developments in Hypotension Pipeline

6 Appendix

For more information about this report visit https://www.researchandmarkets.com/research/srfrcf/hypotension_drug?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery, Cardiovascular Drugs , Clinical Trials

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery, Cardiovascular Drugs , Clinical Trials